CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Iomai Corporation is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Iomai Corporation
910 Clopper Road, Suite 160S
Phone: (301) 556-4537p:301 556-4537 GAITHERSBURG, MD  20878  United States Fax: (301) 556-4505f:301 556-4505
This company ceased filing statements with the SEC on 8/14/2008.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Iomai Corporation is a United States-based specialty vaccine company that provides prevention against diseases with unmet medical needs. The Company focuses on the marketing and distribution of Valneva's Japanese encephalitis vaccine, IXIARO in the United States. IXIARO is a vaccine indicated for the prevention of disease caused by Japanese encephalitis (JE) virus, approved for use in individuals 2 months of age and older.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/200812/31/2007YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
2836 Biological products, except diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Vice President, Operations Mervyn L.Hamer
Vice President of Human Resources Jin-SookChung 12/31/2006 12/1/2006
Vice President, Clinical Affairs SarahFrech
6 additional Officers and Directors records available in full report.

Business Names
Business Name
IOMAI CORP
Iomai Corp.
Iomai Corporation
IOMI

General Information
Number of Employees: 112 (As of 12/31/2007)
Outstanding Shares: 25,601,344 (As of 5/5/2008)
Shareholders: 1,220
Stock Exchange: NASD
Federal Tax Id: 522049149
Fax Number: (301) 556-4505


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023